We previously generated CyTOF data using PBMCs from patients with PDAC treated with ipilimumab, a checkpoint immunotherapy targeting CTLA-4, and a GM-CSF–secreting allogeneic pancreatic cancer vaccine (GVAX). This evidence concerns the gene CTLA4 and pancreatic neoplasm.